“ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER”. 2024. Western European Journal of Medicine and Medical Science 2 (6): 11-20. https://westerneuropeanstudies.com/index.php/3/article/view/1131.